Search research articles
Contact Us
Filters
Showing results (71-80 of 76) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 76 results.
Journal of Leukocyte Biology
|
March 1, 1991
Chemotactic activity and receptor binding of neutrophil attractant/activation protein-1 (NAP-1) and structurally related host defense cytokines: interaction of NAP-2 with the NAP-1 receptor
E J Leonard, T Yoshimura, A Rot, et al.
Biochemical and Biophysical Research Communications
|
September 15, 1989
Connective tissue activation. XXXIII. Biologically active cleavage products of CTAP-III from human platelets
C W Castor, D A Walz, C G Ragsdale, et al.
Arthritis and Rheumatism
|
August 1, 1993
Connective tissue activation. XXXVI. The origin, variety, distribution, and biologic fate of connective tissue activating peptide-III isoforms: characteristics in patients with rheumatic, renal, and arterial disease
C W Castor, P C Andrews, R D Swartz, et al.
Arthritis and Rheumatism
|
March 1, 1979
Connective tissue activation. XIV. Composition and actions of a human platelet autacoid mediator
C W Castor, J C Ritchie, C H Williams, et al.
The Journal of Clinical Investigation
|
May 1, 1990
Relationship of one form of human histamine-releasing factor to connective tissue activating peptide-III
M L Baeza, S R Reddigari, D Kornfeld, et al.
The Journal of Laboratory and Clinical Medicine
|
October 1, 1990
Connective tissue activation. XXXIV: Effects of proteolytic processing on the biologic activities of CTAP-III
C W Castor, D A Walz, P H Johnson, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 76) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 76 results.
Journal of Leukocyte Biology
|
March 1, 1991
Chemotactic activity and receptor binding of neutrophil attractant/activation protein-1 (NAP-1) and structurally related host defense cytokines: interaction of NAP-2 with the NAP-1 receptor
E J Leonard, T Yoshimura, A Rot, et al.
Biochemical and Biophysical Research Communications
|
September 15, 1989
Connective tissue activation. XXXIII. Biologically active cleavage products of CTAP-III from human platelets
C W Castor, D A Walz, C G Ragsdale, et al.
Arthritis and Rheumatism
|
August 1, 1993
Connective tissue activation. XXXVI. The origin, variety, distribution, and biologic fate of connective tissue activating peptide-III isoforms: characteristics in patients with rheumatic, renal, and arterial disease
C W Castor, P C Andrews, R D Swartz, et al.
Arthritis and Rheumatism
|
March 1, 1979
Connective tissue activation. XIV. Composition and actions of a human platelet autacoid mediator
C W Castor, J C Ritchie, C H Williams, et al.
The Journal of Clinical Investigation
|
May 1, 1990
Relationship of one form of human histamine-releasing factor to connective tissue activating peptide-III
M L Baeza, S R Reddigari, D Kornfeld, et al.
The Journal of Laboratory and Clinical Medicine
|
October 1, 1990
Connective tissue activation. XXXIV: Effects of proteolytic processing on the biologic activities of CTAP-III
C W Castor, D A Walz, P H Johnson, et al.
Page
of 8